Robert A. Steiner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert A. Steiner has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Albert Quintana
Institut de Neurociències, Universitat Autònoma de Barcelona
1 shared publication - Elisenda Sanz
Institut de Neurociencies and Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain
1 shared publication - G. Stanley McKnight
Department of Pharmacology, University of Washington, Seattle, Washington
1 shared publication - Jennifer D. Deem
UW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, United States
1 shared publication Matthew J. Cunningham
University of Washington
1 shared publication- Muhammad Shahab
Pakistan Neuroendocrine Group, Laboratory of Reproductive Neuroendocrinology, Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan
1 shared publication
Latest Publications
- Open Access
- 8 April 2015
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 35 (14) , 5549-5556
Fertility-Regulating Kiss1 Neurons Arise from HypothalamicPomc-Expressing Progenitors
Hypothalamic neuronal populations are central regulators of energy homeostasis and reproductive function. However, the ontogeny of these critical hypothalamic neuronal populations is largely unknown. We developed a novel approach to examine the developmental pathways that link specific subtypes of neurons by combining embryonic and adult ribosome-tagging strategies in mice. This new method shows thatPomc-expressing precursors not only differentiate into discrete neuronal populations that mediate energy balance (POMC and AgRP neurons), but also into neurons critical for puberty onset and the regulation of reproductive function (Kiss1 neurons). These results demonstrate a developmental link between nutrient-sensing and reproductive neuropeptide synthesizing neuronal populations and suggest a potential pathway that could link maternal nutrition to reproductive development in the offspring.
- 8 April 2015
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 35 (14) , 5549-5556
Open AccessFertility-Regulating Kiss1 Neurons Arise from HypothalamicPomc-Expressing Progenitors
Hypothalamic neuronal populations are central regulators of energy homeostasis and reproductive function. However, the ontogeny of these critical hypothalamic neuronal populations is largely unknown. We developed a novel approach to examine the developmental pathways that link specific subtypes of neurons by combining embryonic and adult ribosome-tagging strategies in mice. This new method shows thatPomc-expressing precursors not only differentiate into discrete neuronal populations that mediate energy balance (POMC and AgRP neurons), but also into neurons critical for puberty onset and the regulation of reproductive function (Kiss1 neurons). These results demonstrate a developmental link between nutrient-sensing and reproductive neuropeptide synthesizing neuronal populations and suggest a potential pathway that could link maternal nutrition to reproductive development in the offspring.
- 1 September 2005
- Published by S. Karger AG in Neuroendocrinology
- Vol. 81 (4) , 254-258
Galanin-Like Peptide Elicits a Robust Discharge of Growth Hormone in the Rhesus Monkey (Macaca mulatta)
Galanin-like peptide (GALP) stimulates the release of gonadotropin-releasing hormone in rodent and primate species. The widespread distribution of GALP fibers in the hypothalamus suggests that this neuropeptide may influence hypophysiotropic factors that control other aspects of adenohypophysial function. Here we studied the effects of intracerebroventricular administration of GALP on serum levels of growth hormone (GH) and prolactin (PRL) in adult male monkeys. The animals (n = 5) were orchidectomized and implanted with testosterone-containing Silastic capsules to maintain the circulating testosterone levels (∼9 ng/ml) within the physiological range. The animals were implanted with an intracerebroventricular cannula and venous catheter for continuous access to the cerebroventricular and the venous circulation, respectively. GALP (500 µg), or vehicle alone, was administered as a bolus intracerebroventricular injection, and sequential blood samples were collected at 20-min intervals for 3 h before and after the injections. Within 20 min following GALP injection, the GH concentrations increased 3.5-fold, and a peak level (12.9 ± 2.7 ng/ml) was observed 40 min after injection. The GH levels remained elevated until 60 min after injection and thereafter declined to values similar to those observed at 0 min. The GH concentrations were not changed by vehicle alone. A decline in PRL levels was observed following GALP administration, with significantly reduced concentrations occurring between 60 and120 min following the injection of the neuropeptide. We conclude that in the monkey GALP is a potent secretagogue for GH and an inhibitor of PRL secretion and that GALP may, therefore, interact with the hypothalamic circuitry involved in the regulation of these pituitary hormones.
- 1 September 2005
- Published by S. Karger AG in Neuroendocrinology
- Vol. 81 (4) , 254-258
Galanin-Like Peptide Elicits a Robust Discharge of Growth Hormone in the Rhesus Monkey (Macaca mulatta)
Galanin-like peptide (GALP) stimulates the release of gonadotropin-releasing hormone in rodent and primate species. The widespread distribution of GALP fibers in the hypothalamus suggests that this neuropeptide may influence hypophysiotropic factors that control other aspects of adenohypophysial function. Here we studied the effects of intracerebroventricular administration of GALP on serum levels of growth hormone (GH) and prolactin (PRL) in adult male monkeys. The animals (n = 5) were orchidectomized and implanted with testosterone-containing Silastic capsules to maintain the circulating testosterone levels (∼9 ng/ml) within the physiological range. The animals were implanted with an intracerebroventricular cannula and venous catheter for continuous access to the cerebroventricular and the venous circulation, respectively. GALP (500 µg), or vehicle alone, was administered as a bolus intracerebroventricular injection, and sequential blood samples were collected at 20-min intervals for 3 h before and after the injections. Within 20 min following GALP injection, the GH concentrations increased 3.5-fold, and a peak level (12.9 ± 2.7 ng/ml) was observed 40 min after injection. The GH levels remained elevated until 60 min after injection and thereafter declined to values similar to those observed at 0 min. The GH concentrations were not changed by vehicle alone. A decline in PRL levels was observed following GALP administration, with significantly reduced concentrations occurring between 60 and120 min following the injection of the neuropeptide. We conclude that in the monkey GALP is a potent secretagogue for GH and an inhibitor of PRL secretion and that GALP may, therefore, interact with the hypothalamic circuitry involved in the regulation of these pituitary hormones.